Geron Corp (GERN.O)

GERN.O on Nasdaq

3.23USD
28 Aug 2015
Change (% chg)

$0.15 (+4.87%)
Prev Close
$3.08
Open
$3.09
Day's High
$3.23
Day's Low
$3.05
Volume
1,850,308
Avg. Vol
2,359,531
52-wk High
$4.67
52-wk Low
$1.76

GERN.O

Chart for GERN.O

About

Geron Corporation (Geron) is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company operates in one segment, the discovery and development of therapeutic products for oncology. Telomerase is an enzyme that enables cancer cells,... (more)

Overall

Beta: 2.16
Market Cap(Mil.): $510.80
Shares Outstanding(Mil.): 158.14
Dividend: --
Yield (%): --

Financials

  GERN.O Industry Sector
P/E (TTM): -- 70.18 36.13
EPS (TTM): -0.24 -- --
ROI: -28.27 0.47 14.83
ROE: -28.27 0.34 15.69
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks